At the 2023 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, Vital Biosciences introduced its new product, the VitalOne.
The VitalOne intends to bring more than 50 lab-grade test results that cover 95% of routine lab orders to primary care sites in the form of a simple device the size of a desktop computer. The VitalOne will allow doctors to test, diagnose, and treat patients in the course of a single visit. Patients receive their results within 20 minutes. The VitalOne is in late-stage development and is not yet available for sale.
Vital executives on Monday presented to an audience of thousands of lab experts at the annual meeting of the AACC and were selected as Audience Choice winners for this year’s AACC Disruptive Technology Award.